| Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam R Ambrus, P Kocbek, J Kristl, R Šibanc, R Rajkó, P Szabó-Révész International journal of pharmaceutics 381 (2), 153-159, 2009 | 137 | 2009 |
| Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation E Pallagi, R Ambrus, P Szabó-Révész, I Csóka International journal of pharmaceutics 491 (1-2), 384-392, 2015 | 133 | 2015 |
| Alginate and hybrid alginate-hyaluronic acid aerogel microspheres as potential carrier for pulmonary drug delivery T Athamneh, A Amin, E Benke, R Ambrus, CS Leopold, P Gurikov, ... The journal of supercritical fluids 150, 49-55, 2019 | 130 | 2019 |
| Betulinic Acid in Complex with a Gamma-Cyclodextrin Derivative Decreases Proliferation and in Vivo Tumor Development of Non-Metastatic and Metastatic … C Soica, C Danciu, G Savoiu-Balint, F Borcan, R Ambrus, I Zupko, F Bojin, ... International journal of molecular sciences 15 (5), 8235-8255, 2014 | 118 | 2014 |
| Electrospinning of potential medical devices (wound dressings, tissue engineering scaffolds, face masks) and their regulatory approach LÉ Uhljar, R Ambrus Pharmaceutics 15 (2), 417, 2023 | 112 | 2023 |
| In vitro drug release, permeability, and structural test of ciprofloxacin-loaded nanofibers LÉ Uhljar, SY Kan, N Radacsi, V Koutsos, P Szabó-Révész, R Ambrus Pharmaceutics 13 (4), 556, 2021 | 112 | 2021 |
| Intranasal nanoparticulate systems as alternative route of drug delivery A Alshweiat, R Ambrus, II Csóka Current medicinal chemistry 26 (35), 6459-6492, 2019 | 94 | 2019 |
| Formulation and comparison of spray dried non-porous and large porous particles containing meloxicam for pulmonary drug delivery A Chvatal, R Ambrus, P Party, G Katona, O Jójárt-Laczkovich, ... International journal of pharmaceutics 559, 68-75, 2019 | 92 | 2019 |
| Betulin Complex in γ-Cyclodextrin Derivatives: Properties and Antineoplasic Activities in In Vitro and In Vivo Tumor Models C Şoica, C Dehelean, C Danciu, HM Wang, G Wenz, R Ambrus, F Bojin, ... International Journal of Molecular Sciences 13 (11), 14992-15011, 2012 | 83 | 2012 |
| Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach K Karimi, E Pallagi, P Szabó-Révész, I Csóka, R Ambrus Drug design, development and therapy, 3331-3343, 2016 | 80 | 2016 |
| Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid K Takács-Novák, V Szőke, G Völgyi, P Horváth, R Ambrus, ... Journal of pharmaceutical and biomedical analysis 83, 279-285, 2013 | 74 | 2013 |
| Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: preparation, characterization, and in vivo evaluation A Alshweiat, II Csóka, F Tömösi, T Janáky, A Kovács, R Gáspár, ... International journal of pharmaceutics 579, 119166, 2020 | 71 | 2020 |
| Improvement of ursolic and oleanolic acids’ antitumor activity by complexation with hydrophilic cyclodextrins C Oprean, M Mioc, E Csányi, R Ambrus, F Bojin, C Tatu, M Cristea, A Ivan, ... Biomedicine & Pharmacotherapy 83, 1095-1104, 2016 | 68 | 2016 |
| Design and characterization of loratadine nanosuspension prepared by ultrasonic-assisted precipitation A Alshweiat, G Katona, I Csóka, R Ambrus European journal of pharmaceutical sciences 122, 94-104, 2018 | 67 | 2018 |
| A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation H Akel, R Ismail, G Katona, F Sabir, R Ambrus, I Csóka International Journal of Pharmaceutics 604, 120724, 2021 | 62 | 2021 |
| Drug delivery to macrophages: a review of nano-therapeutics targeted approach for inflammatory disorders and cancer M Mukhtar, H Ali, N Ahmed, R Munir, S Talib, AS Khan, R Ambrus Expert opinion on drug delivery 17 (9), 1239-1257, 2020 | 62 | 2020 |
| Synthesis and statistical optimization of poly (lactic-co-glycolic acid) nanoparticles encapsulating GLP1 analog designed for oral delivery R Ismail, T Sovány, A Gácsi, R Ambrus, G Katona, N Imre, I Csóka Pharmaceutical Research 36 (7), 99, 2019 | 62 | 2019 |
| Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach S Iurian, C Bogdan, I Tomuță, P Szabó-Révész, A Chvatal, SE Leucuța, ... European Journal of Pharmaceutical Sciences 104, 356-365, 2017 | 62 | 2017 |
| Genistein in 1: 1 inclusion complexes with ramified cyclodextrins: theoretical, physicochemical and biological evaluation C Danciu, C Soica, M Oltean, S Avram, F Borcan, E Csanyi, R Ambrus, ... International journal of molecular sciences 15 (2), 1962-1982, 2014 | 62 | 2014 |
| Study of the parameters influencing the co-grinding process for the production of meloxicam nanoparticles L Kürti, Á Kukovecz, G Kozma, R Ambrus, MA Deli, P Szabó-Révész Powder technology 212 (1), 210-217, 2011 | 62 | 2011 |
Norbert RadacsiSenior Lecturer (Associate Professor) at The University of EdinburghVerified email at ed.ac.uk
